Osimertinib for EGFR-mutant non-small cell lung cancer: place in therapy and future perspectives

by Ricciuti, Biagio
Published in J Thorac Dis (2019)

First line osimertinib for the treatment of patients with advanced EGFR-mutant NSCLC

by Ricciuti, Biagio, Chiari, Rita
Published in Transl Lung Cancer Res (2018)

Double aortic arch with right positioned descending thoracic aorta and coexistent aortic kinking

by Ricciuti, Biagio, Rebonato, Alberto, Capodicasa, Enrico
Published in BMJ Case Rep (2015)

Impact of performance status and age on osimertinib efficacy in patients with EGFR-mutant T790M-positive non-small-cell lung cancer

by Lamberti, Giuseppe, Andrini, Elisa, Ricciuti, Biagio
Published in J Thorac Dis (2019)

Melanosis coli or ischaemic colitis? That is the question

by Ricciuti, Biagio, Leone, Maria Comasia, Metro, Giulio
Published in BMJ Case Rep (2015)

Emerging Biomarkers in the Era of Personalized Cancer Medicine

by Ricciuti, Biagio, Leonardi, Giulia C., Brambilla, Marta
Published in Dis Markers (2019)

Immune checkpoint blockade in small cell lung cancer: is there a light at the end of the tunnel?

by Paglialunga, Luca, Salih, Zena, Ricciuti, Biagio, Califano, Raffaele
Published in ESMO Open (2016)

Brigatinib for anaplastic lymphoma kinase-tyrosine kinase inhibitor naïve anaplastic lymphoma kinase-positive advanced non-small cell lung cancer: an effective but still broken opt...

by Ricciuti, Biagio, Lamberti, Giuseppe, Roila, Fausto, Metro, Giulio
Published in Transl Lung Cancer Res (2019)

Afatinib in the first-line treatment of patients with non-small cell lung cancer: clinical evidence and experience

by Ricciuti, Biagio, Baglivo, Sara, De Giglio, Andrea, Chiari, Rita
Published in Ther Adv Respir Dis (2018)

Antitumor activity of larotrectinib in tumors harboring NTRK gene fusions: a short review on the current evidence

by Ricciuti, Biagio, Genova, Carlo, Crinò, Lucio, Libra, Massimo, Leonardi, Giulia Costanza
Published in Onco Targets Ther (2019)

Non-coding RNAs in lung cancer

by Ricciuti, Biagio, Mecca, Carmen, Crinò, Lucio, Baglivo, Sara, Cenci, Matteo, Metro, Giulio
Published in Oncoscience (2014)

Targeting EGFR and ALK in NSCLC: current evidence and future perspective

by Bennati, Chiara, Paglialunga, Luca, Ricciuti, Biagio, Metro, Giulio, Marcomigni, Luca, Gili, Alessio, Crinò, Lucio
Published in Lung Cancer Manag (2016)

Osimertinib in patients with advanced epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer: rationale, evidence and place in therapy

by Ricciuti, Biagio, Baglivo, Sara, Paglialunga, Luca, De Giglio, Andrea, Bellezza, Guido, Chiari, Rita, Crinò, Lucio, Metro, Giulio
Published in Ther Adv Med Oncol (2017)

Enteric-type adenocarcinoma of the lung harbouring a novel KRAS Q22K mutation with concomitant KRAS polysomy: a case report

by Metro, Giulio, Valtorta, Emanuele, Siggillino, Annamaria, Lauricella, Calogero, Cenci, Matteo, Ludovini, Vienna, Minenza, Elisa, Prosperi, Enrico, Ricciuti, Biagio, Rebonato, Alberto, Bassetti, Alessandra, Crinò, Lucio
Published in Ecancermedicalscience (2015)

Use of targeted next generation sequencing to characterize tumor mutational burden and efficacy of immune checkpoint inhibition in small cell lung cancer

by Ricciuti, Biagio, Kravets, Sasha, Dahlberg, Suzanne E., Umeton, Renato, Albayrak, Adem, Subegdjo, Safiya J., Johnson, Bruce E., Nishino, Mizuki, Sholl, Lynette M., Awad, Mark M.
Published in J Immunother Cancer (2019)

Ductal Breast Carcinoma Metastatic to the Stomach Resembling Primary Linitis Plastica in a Male Patient

by Ricciuti, Biagio, Leonardi, Giulia Costanza, Ravaioli, Noemi, De Giglio, Andrea, Brambilla, Marta, Prosperi, Enrico, Ribacchi, Franca, Meacci, Marialuisa, Crinò, Lucio, Maiettini, Daniele, Chiari, Rita, Metro, Giulio
Published in J Breast Cancer (2016)

KRAS mutation and DNA repair and synthesis genes in non-small-cell lung cancer

by Ludovini, Vienna, Ricciuti, Biagio, Tofanetti, Francesca R., Mencaroni, Clelia, Giannarelli, Diana, Sidoni, Angelo, Reda, Maria S., Siggillino, Annamaria, Baglivo, Sara, Crinò, Lucio, Bellezza, Guido, Chiari, Rita, Metro, Giulio
Published in Mol Clin Oncol (2018)

Plasma IL-6 changes correlate to PD-1 inhibitor responses in NSCLC

by Keegan, Alissa, Ricciuti, Biagio, Garden, Padric, Cohen, Limor, Nishihara, Reiko, Adeni, Anika, Paweletz, Cloud, Supplee, Julianna, Jänne, Pasi A, Severgnini, Mariano, Awad, Mark M, Walt, David R
Published in J Immunother Cancer (2020)

A comparison of EGFR mutation status in tissue and plasma cell-free DNA detected by ADx-ARMS in advanced lung adenocarcinoma patients

by Xu, Hanyan, Baidoo, Adam Abdul Hakeem, Su, Shanshan, Ye, Junru, Chen, Chengshui, Xie, Yupeng, Bertolaccini, Luca, Ismail, Mahmoud, Ricciuti, Biagio, Ng, Calvin Sze Hang, Flores, Raja M., Li, Yuping
Published in Transl Lung Cancer Res (2019)

miRNAs and resistance to EGFR—TKIs in EGFR-mutant non-small cell lung cancer: beyond ‘traditional mechanisms’ of resistance

by Ricciuti, Biagio, Mecca, Carmen, Cenci, Matteo, Leonardi, Giulia Costanza, Perrone, Lorenzo, Mencaroni, Clelia, Crinò, Lucio, Grignani, Francesco, Baglivo, Sara, Chiari, Rita, Sidoni, Angelo, Paglialunga, Luca, Currà, Maria Francesca, Murano, Emanuele, Minotti, Vincenzo, Metro, Giulio
Published in Ecancermedicalscience (2015)